|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/165 | |
| A61K 31/223 | |||
| A61K 31/5375 | |||
| A61K 31/495 | |||
| A61P 25/32 | |||
| A61K 31/40 | |||
| A61K 31/4453 | |||
| A61P 25/34 | |||
| A61P 25/36 | |||
| A61K 31/167 |
| (11) | Number of the document | 3552604 |
| (13) | Kind of document | T |
| (96) | European patent application number | 19163769.3 |
| Date of filing the European patent application | 2010-06-10 | |
| (97) | Date of publication of the European application | 2019-10-16 |
| (45) | Date of publication and mention of the grant of the patent | 2020-12-16 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 49256609 | 2009-06-26 | US |
| (72) |
LEE, Sung James, US
MELNICK, Susan, Marie, US
|
| (73) |
SK Biopharmaceuticals Co., Ltd.,
99, Seorin-dong Jongro-gu, Seoul 110-728,
KR
|
| (54) | COMPOSITIONS FOR TREATING DRUG ADDICTION AND IMPROVING ADDICTION-RELATED BEHAVIOR |
| COMPOSITIONS FOR TREATING DRUG ADDICTION AND IMPROVING ADDICTION-RELATED BEHAVIOR |